News

Researchers have developed biosensor technology that, when combined with artificial intelligence, shows promise for detecting lung cancer through breath analysis.

Researchers from the Harvard T.H. Chan School of Public Health reveal new insights into how melanoma cells in lymph nodes survive by relying on FSP1, and how this could be targeted therapeutically.

A specific subtype of tumor-associated macrophage is more abundant in endocrine therapy-resistant tumors, and targeting these could improve treatment.

By delivering an immune-stimulating molecule alongside immunotherapy, nanoparticles help the immune system attack ovarian tumors.

New compound fragment disables cancer cells’ antioxidant defenses, paving the way for a next-generation treatment strategy that could work across multiple tumor types.

Targeting a specialized group of histones is safe and opens new therapeutic opportunities for treating blood cancers, a new study reveals.

The study demonstrates how MENPs can be guided by magnetic fields to target pancreatic tumors and activated remotely to destroy cancer cells while providing real-time imaging.

A hidden structure inside the cell is rewriting how scientists understand leukemia, inspiring new kinds of treatments.

Scientific review discusses how new advances in 3D bioprinting, organoids, organs on-a-chip aid in the fight against cancer.

Stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells can force tumors to self-destruct.